Posted in | News

Chemtrade Expand Caustic Soda Handling Facilities at Rotterdam

Chemtrade Logistics Income Fund announced today that its wholly-owned international subsidiary, BCT Chemtrade Corporation, has substantially enhanced its long term business relationship with Bayer MaterialScience AG of Leverkusen, Germany. BCT Chemtrade and Bayer have entered into a long term agreement for the storage of caustic soda at BCT Chemtrade's Rotterdam Terminal, which will be expanded to handle increased throughput. Charges include a fixed fee for the terminal services provided and additional fees if the throughput exceeds the contracted amount.

Chemtrade has agreed to expand its existing terminal facility at a cost of approximately EUR 3.5 million, increasing total storage capacity to 100,000 tonnes. In addition, Chemtrade has agreed to build an additional jetty for the loading and unloading of seagoing vessels and barges, thereby improving its ability to optimize the use of its facilities. The jetty expansion which is expected to cost approximately EUR 2.9 million will be financed by the Port of Rotterdam. Construction is expected to begin in the fall of 2007 and be completed by June 2008.

Mark Davis, Chief Executive Officer of Chemtrade, said, "We are very pleased with this new agreement. It demonstrates the excellent relationship that exists between BCT and a key customer and our team's ability to work with our customers to find value added solutions for both parties. Additionally, this project, like our acquisition of the Olin SHS business in May, is clear evidence of our ability to continually improve and strengthen our business. The agreement with Bayer MaterialScience AG is consistent with our desired business model of adding earnings that are not affected by changes in commodity pricing."

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.